CareCloud Emerges as a Top Gainer in Russell Microcap Index for Q2 2025 with 70% Quarterly Increase
CareCloud (Nasdaq: CCLD), a healthcare technology and revenue cycle management solutions provider, reported a remarkable 70% stock price increase in Q2 2025, emerging as one of the top gainers in the Russell Microcap® Index. The company was officially added to the index on June 30, 2025.
Key developments include the launch of an AI Center of Excellence, resumed M&A activities, conversion of 3.5 million Series A Preferred shares into Common Stock, and a healthy cash position of over $10 million. The company's strategic focus on AI innovation and intelligent health solutions positions it for continued growth in 2025.
CareCloud (Nasdaq: CCLD), fornitore di soluzioni tecnologiche per la sanità e gestione del ciclo dei ricavi, ha registrato un notevole aumento del prezzo delle azioni del 70% nel secondo trimestre 2025, emergendo come uno dei maggiori guadagni nell'indice Russell Microcap®. L'azienda è stata ufficialmente inserita nell'indice il 30 giugno 2025.
Tra gli sviluppi chiave si segnalano il lancio di un Centro di Eccellenza per l'Intelligenza Artificiale, la ripresa delle attività di fusioni e acquisizioni, la conversione di 3,5 milioni di azioni privilegiate di Serie A in azioni ordinarie e una solida posizione di cassa di oltre 10 milioni di dollari. L'attenzione strategica dell'azienda sull'innovazione AI e soluzioni sanitarie intelligenti la pone in una posizione favorevole per una crescita continua nel 2025.
CareCloud (Nasdaq: CCLD), proveedor de tecnología sanitaria y soluciones de gestión del ciclo de ingresos, reportó un notable aumento del precio de sus acciones del 70% en el segundo trimestre de 2025, convirtiéndose en uno de los principales ganadores en el índice Russell Microcap®. La compañía fue añadida oficialmente al índice el 30 de junio de 2025.
Los desarrollos clave incluyen el lanzamiento de un Centro de Excelencia en IA, la reanudación de actividades de fusiones y adquisiciones, la conversión de 3.5 millones de acciones preferentes Serie A en acciones comunes y una sólida posición de efectivo de más de 10 millones de dólares. El enfoque estratégico de la empresa en la innovación en IA y soluciones de salud inteligentes la posiciona para un crecimiento continuo en 2025.
CareCloud (나스닥: CCLD)는 헬스케어 기술 및 수익 주기 관리 솔루션 제공업체로서 2025년 2분기에 주가가 70% 급등하며 Russell Microcap® 지수에서 상위 상승 종목 중 하나로 부상했습니다. 회사는 2025년 6월 30일에 공식적으로 해당 지수에 편입되었습니다.
주요 발전 사항으로는 AI 우수 센터 설립, 인수합병 활동 재개, 350만 주의 시리즈 A 우선주를 보통주로 전환, 그리고 1,000만 달러 이상의 현금 보유가 있습니다. 회사는 AI 혁신과 지능형 헬스 솔루션에 전략적으로 집중하여 2025년에도 지속적인 성장이 기대됩니다.
CareCloud (Nasdaq : CCLD), fournisseur de solutions technologiques pour la santé et de gestion du cycle des revenus, a enregistré une augmentation remarquable de 70 % du cours de son action au deuxième trimestre 2025, se positionnant parmi les meilleurs performeurs de l'indice Russell Microcap®. La société a été officiellement ajoutée à l'indice le 30 juin 2025.
Les développements clés comprennent le lancement d'un Centre d'Excellence en IA, la reprise des activités de fusions et acquisitions, la conversion de 3,5 millions d'actions privilégiées de série A en actions ordinaires, ainsi qu'une trésorerie saine de plus de 10 millions de dollars. L'orientation stratégique de l'entreprise vers l'innovation en IA et les solutions de santé intelligentes la positionne pour une croissance continue en 2025.
CareCloud (Nasdaq: CCLD), ein Anbieter von Gesundheitstechnologie- und Revenue-Cycle-Management-Lösungen, verzeichnete im zweiten Quartal 2025 einen bemerkenswerten Aktienkursanstieg von 70% und gehörte damit zu den Spitzenreitern im Russell Microcap® Index. Das Unternehmen wurde am 30. Juni 2025 offiziell in den Index aufgenommen.
Zu den wichtigsten Entwicklungen zählen die Gründung eines AI Center of Excellence, die Wiederaufnahme von M&A-Aktivitäten, die Umwandlung von 3,5 Millionen Series A Preferred Shares in Stammaktien sowie eine gesunde Barreserve von über 10 Millionen US-Dollar. Die strategische Ausrichtung des Unternehmens auf KI-Innovation und intelligente Gesundheitslösungen positioniert es für weiteres Wachstum im Jahr 2025.
- Stock price surged 70% in Q2 2025
- Added to Russell Microcap Index, increasing visibility
- Conversion of 3.5 million Series A Preferred shares to Common Stock improves capital structure
- Strong cash position of over $10 million
- Resumed M&A activity for potential growth
- Microcap status indicates relatively small market capitalization
- M&A activities could pose integration risks and potential dilution
SOMERSET, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that its common stock rose approximately
The Company was officially added to the Russell Microcap Index effective June 30, 2025, following the annual reconstitution of the Russell indexes. The inclusion and strong performance underscore CareCloud’s growing visibility and investor confidence in its strategic direction.
“Our performance this quarter reflects growing investor confidence in our strategic direction, particularly as we accelerate AI innovation, re-engage in targeted acquisitions, and enhance our capital structure,” said Stephen Snyder, Co-CEO of CareCloud. “With a strengthened balance sheet, an expanding public float, and a renewed focus on delivering intelligent health solutions, we believe CareCloud is well positioned for long-term growth.”
First Half 2025 Highlights:
- Launched its new AI Center of Excellence
- Resumed M&A activity targeting high-potential verticals
- Completed conversion of 3.5 million Series A Preferred shares into Common Stock
- Ended the quarter with over
$10 million in cash - Added to the Russell Microcap Index
The Company believes that these developments reflect CareCloud’s disciplined execution and position the Company for continued momentum into the second half of 2025.
About CareCloud
CareCloud, Inc. is a leading provider of healthcare technology solutions for medical practices and health systems. CareCloud’s comprehensive suite of revenue cycle, practice management, and patient engagement solutions is supported by emerging AI technologies to improve clinical and financial outcomes.
Follow CareCloud on LinkedIn, X and Facebook.
For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.
Disclaimer
This press release is for information purposes only and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions. Past operational or stock price performance is not an indication of future performance.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE: CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Stephen Snyder
Co-Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com
FAQ
What was CareCloud's (CCLD) stock performance in Q2 2025?
When was CareCloud (CCLD) added to the Russell Microcap Index?
How many Series A Preferred shares did CareCloud (CCLD) convert in 2025?
What is CareCloud's (CCLD) cash position in Q2 2025?
What are CareCloud's (CCLD) strategic initiatives for 2025?
